马上注册,结交更多好友,享用更多功能,让你轻松玩转社区。
您需要 登录 才可以下载或查看,没有账号?立即注册
x
《Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells, leading to better nivolumab outcomes in patients with lung cancer》3 ^( m$ a, i$ T) N' n5 q4 R7 S
# K7 r6 x, N4 m# N* i, p$ r
这是日本的一个O药联合或者不联合吸氢气治疗非小细胞肺癌的前瞻性随机对照试验。* c7 H* e2 n6 w! O& ~1 a
# W% R4 K) f5 X" i; f e# n7 B制氢机出气量等情况是这样:“The Hycellvator ET 100 (Helix Japan, Co., Ltd.) generates 1.67 l/ min hydrogen gas (hydrogen purity, 99.99%) by electrolysis. As measured by gas chromatography at Kureha Special Laboratory, the gas generated 680,000 ppm hydrogen gas and 320,000 ppm oxygen gas. Recently, hydrogen gas inhalation was used in patients with post-cardiac arrest syndrome, and adverse events were not observed”- r- Z M* Y1 w, p4 ?0 b4 f
* K4 K! \! r. ^4 d患者每天吸三个小时氢气。 R2 Y/ m2 D, K: j0 s2 N
% g! u! G" x$ a% t! E% v( ?# j60个月的随访,临床试验结果是:“Kaplan-Meyer analysis showed that the HGN-treated patients had a significantly longer OS than those treated with NO (Fig. 1A). Median survival time (MST) for the HGN-treated patients was 28 months, a length that is approximately 3-fold longer than that for NO-treated patients (MST 9 months) (Fig. 1A).”
6 a4 d8 \3 k. k% X 6 V+ u+ g. P% R7 o: X
联合吸氢组的中位生存期是28月,不联合吸氢组的中位生存期是9个月。" P& @% `5 |. ]
, K$ C9 P* }* p, c1 C3 O1 x0 R' Y0 \研究者认为联合吸氢组疗效更好的原因是 “Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells。”4 j$ G! w( P1 |# Y$ \+ h
, G+ ~ o6 n5 n2 @" M
研究者在临床试验基线和过程中检测了入组患者的血液辅酶Q10的含量极其变化。3 ]* K+ D0 b6 z( U3 E8 a" l; |' I
& C& v1 I$ H/ ~
“We measured the CoQ10 concentration in the 35 HGN-treated patients with stage IV lung cancer and investigated its association with OS. The cut-off value was found to be 0.985 µg/ml (ROC curve; AUC=0.803, Sensitivity=83.3%, Specificity=81.8%, (Fig. 2E). Further, the 35 HGN-treated patients were stratified as having high (>0.985 µg/ml) and low (<0.985 µg/ml) CoQ10 concentrations. There were no significant differences in the clinico-pathological factors between patients with high and low CoQ10 (Table III). Patients with high CoQ10 had a significantly longer OS than those with low CoQ10 (Fig. 2F). MST of patients with high CoQ10 was 25 months, while that of patients with low CoQ10 was 8 months (Fig. 2F).”
* b- h2 a3 e* H, v3 A t1 V0 D 0 q: q2 Q" m, x5 ?
“Following hydrogen gas treatment, the concentration of CoQ10 was increased in 19 (46%) of 41 patients (Table IV). Hence, we proceeded to calculate the rate of change of CoQ10 by hydrogen gas treatment (CoQ10 ratio=CoQ10 concentration after treatment/CoQ10 concentration before treatment) and classified patients by high- and low-CoQ10 ratio using the cut-off value (1.175) (ROC curve; AUC=0.710, Sensitivity=75.0%, Specificity=66.7%) (Fig. 2G). Patients with a high-CoQ10 ratio survived significantly longer than those with a low-CoQ10 ratio, as shown in Fig. 2H. MST of patients with a high CoQ10 ratio was NR (not reached to 50% overall survival), while that of patients with low CoQ10 was 9 months (Fig. 2H).”
& L3 j7 C. Y2 L' k/ p
) O, @. Z9 A3 ?6 X+ n1 O# i血液辅酶Q10浓度高的患者,用icb的OS更长。2 T N/ Y4 j& ?+ |( O8 l x- U
|